LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 30

Search options

  1. Article ; Online: When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?

    Lockhart, Sam M / O'Rahilly, Stephen

    Med (New York, N.Y.)

    2020  Volume 1, Issue 1, Page(s) 33–42

    Abstract: A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19, including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the ... ...

    Abstract A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19, including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the mechanisms underlying the adverse health consequences of obesity, we present some hypotheses regarding the deleterious impact of obesity on the course of COVID-19. These hypotheses are testable and could guide therapeutic and preventive interventions. As obesity is now almost ubiquitous and no vaccine for COVID-19 is currently available, even a modest reduction in the impact of obesity on mortality and morbidity from this viral infection could have profound consequences for public health.
    MeSH term(s) COVID-19/epidemiology ; Humans ; Obesity/epidemiology ; Pandemics ; Public Health ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-06-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ISSN 2666-6340
    ISSN (online) 2666-6340
    DOI 10.1016/j.medj.2020.06.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: When Two Pandemics Meet

    Lockhart, Sam M. / O’Rahilly, Stephen

    Med ; ISSN 2666-6340

    Why Is Obesity Associated with Increased COVID-19 Mortality?

    2020  

    Keywords covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    DOI 10.1016/j.medj.2020.06.005
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells.

    Kunkemoeller, Britta / Chen, Kuangyang / Lockhart, Sam M / Wang, Xuanchun / Rask-Madsen, Christian

    American journal of physiology. Endocrinology and metabolism

    2021  Volume 321, Issue 2, Page(s) E252–E259

    Abstract: Endothelial cell insulin resistance contributes to the development of vascular complications in diabetes. Hypoxia-inducible factors (HIFs) modulate insulin sensitivity, and we have previously shown that a negative regulator of HIF activity, CREB-binding ... ...

    Abstract Endothelial cell insulin resistance contributes to the development of vascular complications in diabetes. Hypoxia-inducible factors (HIFs) modulate insulin sensitivity, and we have previously shown that a negative regulator of HIF activity, CREB-binding protein/p300 (CBP/p300) interacting transactivator-2 (CITED2), is increased in the vasculature of people with type 2 diabetes. Therefore, we examined whether CITED2 regulates endothelial insulin sensitivity. In endothelial cells isolated from mice with a "floxed" mutation in the
    MeSH term(s) Animals ; Basic Helix-Loop-Helix Transcription Factors/metabolism ; Endothelial Cells/metabolism ; Gene Expression Regulation ; Insulin/metabolism ; Insulin Receptor Substrate Proteins/metabolism ; Mice ; Repressor Proteins/metabolism ; Signal Transduction ; Trans-Activators/metabolism
    Chemical Substances Basic Helix-Loop-Helix Transcription Factors ; Cited2 protein, mouse ; Insulin ; Insulin Receptor Substrate Proteins ; Irs2 protein, mouse ; Repressor Proteins ; Trans-Activators ; endothelial PAS domain-containing protein 1 (1B37H0967P)
    Language English
    Publishing date 2021-06-21
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00435.2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?

    Lockhart, Sam M / O039, / Rahilly, Stephen

    Abstract: A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19, including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the ... ...

    Abstract A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19, including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the mechanisms underlying the adverse health consequences of obesity, we present some hypotheses regarding the deleterious impact of obesity on the course of COVID-19. These hypotheses are testable and could guide therapeutic and preventive interventions. As obesity is now almost ubiquitous and no vaccine for COVID-19 is currently available, even a modest reduction in the impact of obesity on mortality and morbidity from this viral infection could have profound consequences for public health.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #628996
    Database COVID19

    Kategorien

  5. Article ; Online: When Two Pandemics Meet

    Lockhart, Sam M / O'Rahilly, Stephen

    Why Is Obesity Associated with Increased COVID-19 Mortality?

    2020  

    Abstract: A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19 including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the ... ...

    Abstract A growing body of evidence indicates that obesity is strongly and independently associated with adverse outcomes of COVID-19 including death. By combining emerging knowledge of the pathological processes involved in COVID-19 with insights into the mechanisms underlying the adverse health consequences of obesity, we present some hypotheses regarding the deleterious impact of obesity on the course of COVID-19. These hypotheses are testable and could guide therapeutic and preventive interventions. As obesity is now almost ubiquitous and no vaccine for COVID-19 is currently available, even a modest reduction in the impact of obesity on mortality and morbidity from this viral infection could have profound consequences for public health.
    Keywords covid19
    Language English
    Publishing date 2020-06-29
    Publisher Elsevier
    Publishing country uk
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article: Usefulness of Heat Map Explanations for Deep-Learning-Based Electrocardiogram Analysis.

    Storås, Andrea M / Andersen, Ole Emil / Lockhart, Sam / Thielemann, Roman / Gnesin, Filip / Thambawita, Vajira / Hicks, Steven A / Kanters, Jørgen K / Strümke, Inga / Halvorsen, Pål / Riegler, Michael A

    Diagnostics (Basel, Switzerland)

    2023  Volume 13, Issue 14

    Abstract: Deep neural networks are complex machine learning models that have shown promising results in analyzing high-dimensional data such as those collected from medical examinations. Such models have the potential to provide fast and accurate medical diagnoses. ...

    Abstract Deep neural networks are complex machine learning models that have shown promising results in analyzing high-dimensional data such as those collected from medical examinations. Such models have the potential to provide fast and accurate medical diagnoses. However, the high complexity makes deep neural networks and their predictions difficult to understand. Providing model explanations can be a way of increasing the understanding of "black box" models and building trust. In this work, we applied transfer learning to develop a deep neural network to predict sex from electrocardiograms. Using the visual explanation method Grad-CAM, heat maps were generated from the model in order to understand how it makes predictions. To evaluate the usefulness of the heat maps and determine if the heat maps identified electrocardiogram features that could be recognized to discriminate sex, medical doctors provided feedback. Based on the feedback, we concluded that, in our setting, this mode of explainable artificial intelligence does not provide meaningful information to medical doctors and is not useful in the clinic. Our results indicate that improved explanation techniques that are tailored to medical data should be developed before deep neural networks can be applied in the clinic for diagnostic purposes.
    Language English
    Publishing date 2023-07-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662336-5
    ISSN 2075-4418
    ISSN 2075-4418
    DOI 10.3390/diagnostics13142345
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Identification of cancer chemotherapy regimens and patient cohorts in administrative claims: challenges, opportunities, and a proposed algorithm.

    Lockhart, Catherine M / McDermott, Cara L / Mendelsohn, Aaron B / Marshall, James / McBride, Ali / Yee, Gary / Li, Minghui Sam / Jamal-Allial, Aziza / Djibo, Djeneba Audrey / Vazquez Benitez, Gabriela / DeFor, Terese A / Pawloski, Pamala A

    Journal of medical economics

    2023  Volume 26, Issue 1, Page(s) 403–410

    Abstract: Background: Real-world evidence is a valuable source of information in healthcare. This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regimens from claims data to ... ...

    Abstract Background: Real-world evidence is a valuable source of information in healthcare. This study describes the challenges and successes during algorithm development to identify cancer cohorts and multi-agent chemotherapy regimens from claims data to perform a comparative effectiveness analysis of granulocyte colony stimulating factor (G-CSF) use.
    Methods: Using the Biologics and Biosimilars Collective Intelligence Consortium's Distributed Research Network, we iteratively developed and tested a de novo algorithm to accurately identify patients by cancer diagnosis, then extract chemotherapy and G-CSF administrations for a retrospective study of prophylactic G-CSF.
    Results: After identifying patients with cancer and subsequent chemotherapy exposures, we observed only 12% of patients with cancer received chemotherapy, which is fewer than expected based on prior analyses. Therefore, we reversed the initial inclusion criteria to identify chemotherapy receipt, then prior cancer diagnosis, which increased the number of patients from 2,814 to 3,645, or 68% of patients receiving chemotherapy had diagnoses of interest. Additionally, we excluded patients with cancer diagnoses that differed from those of interest in the 183 days before the index date of G-CSF receipt, including early-stage cancers without G-CSF or chemotherapy exposure. By removing this criterion, we retained 77 patients who were previously excluded. Finally, we incorporated a 5-day window to identify all chemotherapy drugs administered (excluding oral prednisone and methotrexate, as these medications may be used for other non-malignant conditions) as patients may fill oral prescriptions days to weeks prior to infusion. This increased the number of patients with chemotherapy exposures of interest to 6,010. The final cohort of included patients, based on G-CSF exposure, increased from 420 from the initial algorithm to 886 using the final algorithm.
    Conclusions: Medications used for multiple indications, sensitivity and specificity of administrative codes, and relative timing of medication exposure must all be evaluated to identify patient cohorts receiving chemotherapy from claims data.
    MeSH term(s) Humans ; Retrospective Studies ; Biosimilar Pharmaceuticals ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Neoplasms/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
    Chemical Substances Biosimilar Pharmaceuticals ; Granulocyte Colony-Stimulating Factor (143011-72-7)
    Language English
    Publishing date 2023-03-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 2270945-9
    ISSN 1941-837X ; 1369-6998
    ISSN (online) 1941-837X
    ISSN 1369-6998
    DOI 10.1080/13696998.2023.2187196
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Author Correction: Proteogenomic links to human metabolic diseases.

    Koprulu, Mine / Carrasco-Zanini, Julia / Wheeler, Eleanor / Lockhart, Sam / Kerrison, Nicola D / Wareham, Nicholas J / Pietzner, Maik / Langenberg, Claudia

    Nature metabolism

    2023  Volume 5, Issue 4, Page(s) 710

    Language English
    Publishing date 2023-03-13
    Publishing country Germany
    Document type Published Erratum
    ISSN 2522-5812
    ISSN (online) 2522-5812
    DOI 10.1038/s42255-023-00785-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Proteogenomic links to human metabolic diseases.

    Koprulu, Mine / Carrasco-Zanini, Julia / Wheeler, Eleanor / Lockhart, Sam / Kerrison, Nicola D / Wareham, Nicholas J / Pietzner, Maik / Langenberg, Claudia

    Nature metabolism

    2023  Volume 5, Issue 3, Page(s) 516–528

    Abstract: Studying the plasma proteome as the intermediate layer between the genome and the phenome has the potential to identify new disease processes. Here, we conducted a cis-focused proteogenomic analysis of 2,923 plasma proteins measured in 1,180 individuals ... ...

    Abstract Studying the plasma proteome as the intermediate layer between the genome and the phenome has the potential to identify new disease processes. Here, we conducted a cis-focused proteogenomic analysis of 2,923 plasma proteins measured in 1,180 individuals using antibody-based assays. We (1) identify 256 unreported protein quantitative trait loci (pQTL); (2) demonstrate shared genetic regulation of 224 cis-pQTLs with 575 specific health outcomes, revealing examples for notable metabolic diseases (such as gastrin-releasing peptide as a potential therapeutic target for type 2 diabetes); (3) improve causal gene assignment at 40% (n = 192) of overlapping risk loci; and (4) observe convergence of phenotypic consequences of cis-pQTLs and rare loss-of-function gene burden for 12 proteins, such as TIMD4 for lipoprotein metabolism. Our findings demonstrate the value of integrating complementary proteomic technologies with genomics even at moderate scale to identify new mediators of metabolic diseases with the potential for therapeutic interventions.
    MeSH term(s) Humans ; Proteogenomics ; Proteomics ; Diabetes Mellitus, Type 2/genetics ; Quantitative Trait Loci ; Blood Proteins/genetics
    Chemical Substances Blood Proteins
    Language English
    Publishing date 2023-02-23
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2522-5812
    ISSN (online) 2522-5812
    DOI 10.1038/s42255-023-00753-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Olfactory dysfunction in the 3xTg-AD model of Alzheimer's disease.

    Mitrano, Darlene A / Houle, Sam E / Pearce, Patrick / Quintanilla, Ricardo M / Lockhart, Blakely K / Genovese, Benjamin C / Schendzielos, Rachel A / Croushore, Emma E / Dymond, Ethan M / Bogenpohl, James W / Grau, Harold J / Webb, Lisa Smith

    IBRO neuroscience reports

    2021  Volume 10, Page(s) 51–61

    Abstract: Alzheimer's disease (AD) is an incurable neurodegenerative disease in which the risk of development increases with age. People with AD are plagued with deficits in their cognition, memory, and basic social skills. Many of these deficits are believed to ... ...

    Abstract Alzheimer's disease (AD) is an incurable neurodegenerative disease in which the risk of development increases with age. People with AD are plagued with deficits in their cognition, memory, and basic social skills. Many of these deficits are believed to be caused by the formation of amyloid-β plaques and neurofibrillary tangles in regions of the brain associated with memory, such as the hippocampus. However, one of the early, preclinical symptoms of AD is the loss of olfactory detection and discrimination. To determine if a mouse model of AD expresses the same olfactory dysfunction seen in human AD, 3xTg-AD mice were given a buried food test and, unlike previous studies, compared to their background and parental strains. Results showed that over 52 weeks, the 3xTg-AD mice took significantly longer to find the buried food than the control strains. The olfactory bulbs of the 3xTg-AD mice were removed, sliced, and stained using Congo red for histological analysis. Amyloid deposits were observed predominantly in the granule layer of the olfactory bulb beginning at 13 weeks of age in 3xTg-AD mice, but not in the control strains of mice. Further examination of the buried food test data revealed that 3xTg-AD females had a significantly longer latency to detect the buried food than males beginning at 26 weeks of age. Overall, this study provides further validation of the 3xTg-AD mouse model of AD and supports the idea that simple olfactory testing could be part of the diagnostic process for human AD.
    Language English
    Publishing date 2021-01-08
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2667-2421
    ISSN (online) 2667-2421
    DOI 10.1016/j.ibneur.2020.12.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top